Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 125,301 | 126,050 | 37,221 | 0 | 0 |
| Marketable Securities | 102,649 | 127,392 | 54,627 | 0 | 0 |
| TOTAL | $234,829 | $259,634 | $94,544 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 25,739 | 24,802 | 24,290 | N/A | N/A |
| Other Non-Current Assets | 39,407 | 38,202 | 37,265 | 0 | 0 |
| TOTAL | $65,146 | $63,004 | $61,555 | $N/A | $N/A |
| Total Assets | $299,975 | $322,638 | $156,099 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,154 | 6,101 | 7,846 | 0 | 0 |
| Accrued Expenses | 7,202 | 8,480 | 7,852 | 0 | 0 |
| Other current liabilities | 20,896 | 12,160 | 9,103 | 0 | 0 |
| TOTAL | $38,950 | $31,440 | $29,138 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 30,203 | 29,804 | 328,065 | 0 | 0 |
| TOTAL | $30,203 | $29,804 | $328,065 | $N/A | $N/A |
| Total Liabilities | $69,153 | $61,244 | $357,203 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,732 | 51,485 | N/A | N/A | N/A |
| Common Shares | 496 | 491 | 73 | 0 | 0 |
| Retained earnings | -267,720 | -233,502 | -203,044 | 0 | 0 |
| Other shareholders' equity | 173 | -344 | 16 | 0 | 0 |
| TOTAL | $230,822 | $261,394 | $-201,104 | $0 | $0 |
| Total Liabilities And Equity | $299,975 | $322,638 | $156,099 | $0 | $0 |